World Health Organization (WHO)

Through the new framework, WHO and AMA will coordinate efforts to streamline approval processes, enhance post-market surveillance, and build regulatory workforce capacity.

WHO validated the elimination in June 2025, and Kenya made a national announcement in August 2025 before formally receiving the certification in Geneva.

Since the partnership began, Gilead has supplied more than 1.1 million vials of AmBisome and contributed over US$18 million in funding.

Health authorities in DRC and Uganda have already activated emergency response mechanisms, including contact tracing, case isolation, infection prevention measures, and enhanced treatment services.

Globally, new HIV infections declined by 40% between 2010 and 2024, while the number of people requiring interventions for neglected tropical diseases dropped by 36% during the same period.

The achievement places Australia among 63 countries globally and 16 in the WHO Western Pacific Region that have eliminated at least one NTD.

The project received financial backing from First City Monument Bank (FCMB) and the Bank of Industry (BoI), reflecting a coordinated push to support local industry growth.

Current estimates indicate that about 1.9 million people live with blindness or visual impairment caused by trachoma, while approximately 97 million people remain at risk in endemic areas.

Programme implementation concluded on March 31, 2026, with the global initiative on track to exceed its target of reaching at least 21 million under-immunised children.

Nine countries now maintain consistently low measles incidence rates, reporting fewer than five cases per million residents.